These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 20716307)

  • 21. Correlates of psychiatric co-morbidity in a sample of Egyptian patients with bipolar disorder.
    Asaad T; Okasha T; Ramy H; Fekry M; Zaki N; Azzam H; Rabie MA; Elghoneimy S; Sultan M; Hamed H; Refaat O; Shorab I; Elhabiby M; Elgweily T; ElShinnawy H; Nasr M; Fathy H; Meguid MA; Nader D; Elserafi D; Enaba D; Ibrahim D; Elmissiry M; Mohsen N; Ahmed S
    J Affect Disord; 2014 Sep; 166():347-52. PubMed ID: 24981131
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Substance use disorders in adolescent and young adult relatives of probands with bipolar disorder: What drives the increased risk?
    Hulvershorn LA; King J; Monahan PO; Wilcox HC; Mitchell PB; Fullerton JM; Edenberg HJ; Roberts GMP; Kamali M; Glowinski AL; Ghaziuddin N; McInnis M; Iyer-Eimerbrink PA; Nurnberger JI
    Compr Psychiatry; 2017 Oct; 78():130-139. PubMed ID: 28843850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
    Prior K; Mills K; Ross J; Teesson M
    Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Which psychiatric comorbidities in cannabis dependence during adolescence? Comparison of outpatients and controls].
    Dorard G; Bungener C; Phan O; Edel Y; Corcos M; Berthoz S
    Encephale; 2018 Feb; 44(1):2-8. PubMed ID: 27637871
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990-2014: A systematic review and meta-analysis.
    Lai HM; Cleary M; Sitharthan T; Hunt GE
    Drug Alcohol Depend; 2015 Sep; 154():1-13. PubMed ID: 26072219
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The emerging epidemiology of hypomania and bipolar II disorder.
    Angst J
    J Affect Disord; 1998 Sep; 50(2-3):143-51. PubMed ID: 9858074
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Risk factors for secondary substance use disorders in people with childhood and adolescent-onset bipolar disorder: opportunities for prevention.
    Kenneson A; Funderburk JS; Maisto SA
    Compr Psychiatry; 2013 Jul; 54(5):439-46. PubMed ID: 23332720
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Substance use disorders and adoption: findings from a national sample.
    Yoon G; Westermeyer J; Warwick M; Kuskowski MA
    PLoS One; 2012; 7(11):e49655. PubMed ID: 23166740
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The associations between psychotic experiences and substance use and substance use disorders: findings from the World Health Organization World Mental Health surveys.
    Degenhardt L; Saha S; Lim CCW; Aguilar-Gaxiola S; Al-Hamzawi A; Alonso J; Andrade LH; Bromet EJ; Bruffaerts R; Caldas-de-Almeida JM; de Girolamo G; Florescu S; Gureje O; Haro JM; Karam EG; Karam G; Kovess-Masfety V; Lee S; Lepine JP; Makanjuola V; Medina-Mora ME; Mneimneh Z; Navarro-Mateu F; Piazza M; Posada-Villa J; Sampson NA; Scott KM; Stagnaro JC; Ten Have M; Kendler KS; Kessler RC; McGrath JJ;
    Addiction; 2018 May; 113(5):924-934. PubMed ID: 29284197
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Sociodemographic profiles, addictive and mental comorbidity in cannabis users in an outpatient specific setting].
    Guillem E; Pelissolo A; Vorspan F; Bouchez-Arbabzadeh S; Lépine JP
    Encephale; 2009 Jun; 35(3):226-33. PubMed ID: 19540408
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Lifetime comorbidity of DSM-IV mood and anxiety disorders and specific drug use disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions.
    Conway KP; Compton W; Stinson FS; Grant BF
    J Clin Psychiatry; 2006 Feb; 67(2):247-57. PubMed ID: 16566620
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bipolar II disorder: symptoms, course, and response to treatment.
    MacQueen GM; Young LT
    Psychiatr Serv; 2001 Mar; 52(3):358-61. PubMed ID: 11239105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study.
    Toftdahl NG; Nordentoft M; Hjorthøj C
    Soc Psychiatry Psychiatr Epidemiol; 2016 Jan; 51(1):129-40. PubMed ID: 26260950
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multiple DSM-5 substance use disorders: A national study of US adults.
    McCabe SE; West BT; Jutkiewicz EM; Boyd CJ
    Hum Psychopharmacol; 2017 Sep; 32(5):. PubMed ID: 28750478
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The 3-Year Course of Multiple Substance Use Disorders in the United States: A National Longitudinal Study.
    McCabe SE; West BT
    J Clin Psychiatry; 2017 May; 78(5):e537-e544. PubMed ID: 28406266
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
    de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
    Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Lamotrigine adjunctive therapy to lithium and divalproex in depressed patients with rapid cycling bipolar disorder and a recent substance use disorder: a 12-week, double-blind, placebo-controlled pilot study.
    Wang Z; Gao K; Kemp DE; Chan PK; Serrano MB; Conroy C; Fang Y; Ganocy SJ; Findling RL; Calabrese JR
    Psychopharmacol Bull; 2010; 43(4):5-21. PubMed ID: 21240149
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comorbid trajectories of substance use as predictors of Antisocial Personality Disorder, Major Depressive Episode, and Generalized Anxiety Disorder.
    Brook JS; Zhang C; Rubenstone E; Primack BA; Brook DW
    Addict Behav; 2016 Nov; 62():114-21. PubMed ID: 27344118
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Childhood-compared to adolescent-onset bipolar disorder has more statistically significant clinical correlates.
    Holtzman JN; Miller S; Hooshmand F; Wang PW; Chang KD; Hill SJ; Rasgon NL; Ketter TA
    J Affect Disord; 2015 Jul; 179():114-20. PubMed ID: 25863906
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Medical and substance use comorbidity in bipolar disorder.
    Kemp DE; Gao K; Ganocy SJ; Caldes E; Feldman K; Chan PK; Conroy C; Bilali S; Findling RL; Calabrese JR
    J Affect Disord; 2009 Jul; 116(1-2):64-9. PubMed ID: 19100627
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.